Egypt denies rumors on selling archaeological pieces to UK, upping Remdesivir drug used in COVID-19 treatment

BY

-

Thu, 30 Jul 2020 - 10:48 GMT

BY

Thu, 30 Jul 2020 - 10:48 GMT

Egyptian Antiquities - file photo

Egyptian Antiquities - file photo

CAIRO - 30 July 2020: Cabinet's information center has denied a number of rumors on Thursday including selling Egyptian archaeological pieces to UK, and upping price of Remdesivir drug used in treating COVID-19 patients.

The first rumor was on selling Egyptian archaeological pieces to the British Museum in London.

The Ministry of Tourism said that the news is void of truth, the center said in a report on Thursday.
 
"Egypt has intensified efforts to restore stolen and smuggled pieces within the framework of its keenness on maintaining all the Egyptian antiquities and heritage," added the ministry .
 
The second rumor was about banning cotton plantation, which was denied by the Ministry of Agriculture and Land Reclamation 
 
"The state will continue planting all kinds of crops," the ministry said, noting that there are over 182,000 feddans of cotton cultivated across the country. The ministry underlined that the state is keen on realizing self-sufficiency of strategic crops.
 
The ministry is working on developing new varieties of seeds with high quality and productivity rates and resistant to diseases and changing climatic conditions.
 
Laying off 192,000 workers of business sector companies to fulfill conditions imposed by the International Monetary Fund (IMF) was another rumor that was denied by the cabinet as "baseless."
 
And lastly, rumors about increasing the price of Remesivir drug used in Coronavirus treatment, and selling it at pharmacies were denied as void. 
 
"This drug is only used in the quarantine hospital for the critical cases suffering from severe problems in the respiratory system under medical supervision and according to the regulations set by the hospitals to deal with COVID 19 cases," the authority said.
 
The authority is coordinating with the Unified Medical Procurement Authority (UMPA) to provide the medical needs of governmental hospitals and the health insurance within the framework of the state's keenness on presenting distinguished medical services to the citizens.
 
 
<i> Parts of this report were taken from MENA </i>

 

Comments

0

Leave a Comment

Be Social